European Commission and investment bank to “throw weight behind” effort, says von der Leyen
The German biotechnology company BioNTech, which co-developed a widely used vaccine against Covid-19 with the aid of EU funding, has announced that it plans to use the same messenger RNA technology to develop a jab for malaria with the bloc’s support.
Malaria, a disease caused by parasites spread by mosquitoes, kills about 400,000 people every year, mainly in Africa. Over two-thirds of malaria deaths were among children in 2019, according to the World Health Organization (WHO).